Rejuvenation model of dopamine neuron (Chan et al. 2007)


Chan CS et al. (2007). 'Rejuvenation' protects neurons in mouse models of Parkinson's disease. Nature. 447 [PubMed]

See more from authors: Chan CS · Guzman JN · Ilijic E · Mercer JN · Rick C · Tkatch T · Meredith GE · Surmeier DJ

References and models cited by this paper

Abou-Sleiman PM, Muqit MM, Wood NW. (2006). Expanding insights of mitochondrial dysfunction in Parkinson's disease. Nature reviews. Neuroscience. 7 [PubMed]

Ai Y et al. (2003). Intraputamenal infusion of GDNF in aged rhesus monkeys: distribution and dopaminergic effects. The Journal of comparative neurology. 461 [PubMed]

Beal MF. (1998). Excitotoxicity and nitric oxide in Parkinson's disease pathogenesis. Annals of neurology. 44 [PubMed]

Bender A et al. (2006). High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nature genetics. 38 [PubMed]

Betarbet R et al. (2000). Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nature neuroscience. 3 [PubMed]

Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K. (2004). Stages in the development of Parkinson's disease-related pathology. Cell and tissue research. 318 [PubMed]

Bywood PT, Johnson SM. (2003). Mitochondrial complex inhibitors preferentially damage substantia nigra dopamine neurons in rat brain slices. Experimental neurology. 179 [PubMed]

Chan CS, Shigemoto R, Mercer JN, Surmeier DJ. (2004). HCN2 and HCN1 channels govern the regularity of autonomous pacemaking and synaptic resetting in globus pallidus neurons. The Journal of neuroscience : the official journal of the Society for Neuroscience. 24 [PubMed]

Coleman M. (2005). Axon degeneration mechanisms: commonality amid diversity. Nature reviews. Neuroscience. 6 [PubMed]

Coyle JT, Puttfarcken P. (1993). Oxidative stress, glutamate, and neurodegenerative disorders. Science (New York, N.Y.). 262 [PubMed]

Dauer W, Przedborski S. (2003). Parkinson's disease: mechanisms and models. Neuron. 39 [PubMed]

Fahn S, Parkinson Study Group. (2005). Does levodopa slow or hasten the rate of progression of Parkinson's disease? Journal of neurology. 252 Suppl 4 [PubMed]

Grace AA, Bunney BS. (1984). The control of firing pattern in nigral dopamine neurons: single spike firing. The Journal of neuroscience : the official journal of the Society for Neuroscience. 4 [PubMed]

Grace AA, Onn SP. (1989). Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in vitro. The Journal of neuroscience : the official journal of the Society for Neuroscience. 9 [PubMed]

Greenamyre JT, Hastings TG. (2004). Biomedicine. Parkinson's--divergent causes, convergent mechanisms. Science (New York, N.Y.). 304 [PubMed]

Grossman E, Messerli FH, Oren S, Nunez B, Garavaglia GE. (1991). Cardiovascular effects of isradipine in essential hypertension. The American journal of cardiology. 68 [PubMed]

Hines ML, Carnevale NT. (2001). NEURON: a tool for neuroscientists. The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry. 7 [PubMed]

Hornykiewicz O. (1966). Dopamine (3-hydroxytyramine) and brain function. Pharmacological reviews. 18 [PubMed]

Hows ME et al. (2004). High-performance liquid chromatography/tandem mass spectrometry assay for the determination of 1-methyl-4-phenyl pyridinium (MPP+) in brain tissue homogenates. J Neurosci Methods. 137

Jiang Q, Yan Z, Feng J. (2006). Activation of group III metabotropic glutamate receptors attenuates rotenone toxicity on dopaminergic neurons through a microtubule-dependent mechanism. The Journal of neuroscience : the official journal of the Society for Neuroscience. 26 [PubMed]

Johnson BA, Devous MD, Ruiz P, Ait-Daoud N. (2001). Treatment advances for cocaine-induced ischemic stroke: focus on dihydropyridine-class calcium channel antagonists. The American journal of psychiatry. 158 [PubMed]

Kazuno AA et al. (2006). Identification of mitochondrial DNA polymorphisms that alter mitochondrial matrix pH and intracellular calcium dynamics. PLoS genetics. 2 [PubMed]

Kennedy JL, Farrer LA, Andreasen NC, Mayeux R, St George-Hyslop P. (2003). The genetics of adult-onset neuropsychiatric disease: complexities and conundra? Science (New York, N.Y.). 302 [PubMed]

Kish SJ, Shannak K, Hornykiewicz O. (1988). Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. The New England journal of medicine. 318 [PubMed]

Koschak A et al. (2001). alpha 1D (Cav1.3) subunits can form l-type Ca2+ channels activating at negative voltages. The Journal of biological chemistry. 276 [PubMed]

Kraytsberg Y et al. (2006). Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nature genetics. 38 [PubMed]

Krieger C, Duchen MR. (2002). Mitochondria, Ca2+ and neurodegenerative disease. European journal of pharmacology. 447 [PubMed]

Kwong JQ, Beal MF, Manfredi G. (2006). The role of mitochondria in inherited neurodegenerative diseases. Journal of neurochemistry. 97 [PubMed]

Mandir AS et al. (1999). Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism. Proceedings of the National Academy of Sciences of the United States of America. 96 [PubMed]

Maurice N et al. (2004). D2 dopamine receptor-mediated modulation of voltage-dependent Na+ channels reduces autonomous activity in striatal cholinergic interneurons. The Journal of neuroscience : the official journal of the Society for Neuroscience. 24 [PubMed]

Mercuri NB et al. (1994). Effects of dihydropyridine calcium antagonists on rat midbrain dopaminergic neurones. British journal of pharmacology. 113 [PubMed]

Meredith GE, Kang UJ. (2006). Behavioral models of Parkinson's disease in rodents: a new look at an old problem. Movement disorders : official journal of the Movement Disorder Society. 21 [PubMed]

Michel PP, Hefti F. (1990). Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. Journal of neuroscience research. 26 [PubMed]

Migliore M, Cook EP, Jaffe DB, Turner DA, Johnston D. (1995). Computer simulations of morphologically reconstructed CA3 hippocampal neurons. Journal of neurophysiology. 73 [PubMed]

Nedergaard S, Flatman JA, Engberg I. (1993). Nifedipine- and omega-conotoxin-sensitive Ca2+ conductances in guinea-pig substantia nigra pars compacta neurones. The Journal of physiology. 466 [PubMed]

Nelson EL, Liang CL, Sinton CM, German DC. (1996). Midbrain dopaminergic neurons in the mouse: computer-assisted mapping. The Journal of comparative neurology. 369 [PubMed]

Neuhoff H, Neu A, Liss B, Roeper J. (2002). I(h) channels contribute to the different functional properties of identified dopaminergic subpopulations in the midbrain. The Journal of neuroscience : the official journal of the Society for Neuroscience. 22 [PubMed]

Oertel WH et al. (1995). Pretreatment with nimodipine prevents MPTP-induced neurotoxicity at the nigral, but not at the striatal level in mice. Neuroreport. 6

Oertel WH et al. (1996). 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level. Brain Res. 741

Olson PA et al. (2005). G-protein-coupled receptor modulation of striatal CaV1.3 L-type Ca2+ channels is dependent on a Shank-binding domain. The Journal of neuroscience : the official journal of the Society for Neuroscience. 25 [PubMed]

Orrenius S, Zhivotovsky B, Nicotera P. (2003). Regulation of cell death: the calcium-apoptosis link. Nature reviews. Molecular cell biology. 4 [PubMed]

Palmiter RD, Hasbani DM, Perez FA, O'Malley KL. (2005). Dopamine depletion does not protect against acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in vivo. J Neurosci. 25

Paxinos G, Franklin KBJ. (2004). The Mouse Brain in Stereotaxic Coordinates.

Petroske E, Meredith GE, Callen S, Totterdell S, Lau YS. (2001). Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment. Neuroscience. 106 [PubMed]

Phinney AL et al. (2006). Enhanced sensitivity of dopaminergic neurons to rotenone-induced toxicity with aging. Parkinsonism & related disorders. 12 [PubMed]

Platzer J et al. (2000). Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels. Cell. 102 [PubMed]

Przedborski S, Vila M. (2003). The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson's disease. Annals of the New York Academy of Sciences. 991 [PubMed]

Riederer P, Wuketich S. (1976). Time course of nigrostriatal degeneration in parkinson's disease. A detailed study of influential factors in human brain amine analysis. Journal of neural transmission. 38 [PubMed]

Rodnitzky RL. (1999). Can calcium antagonists provide a neuroprotective effect in Parkinson's disease? Drugs. 57 [PubMed]

Scholze A, Plant TD, Dolphin AC, Nürnberg B. (2001). Functional expression and characterization of a voltage-gated CaV1.3 (alpha1D) calcium channel subunit from an insulin-secreting cell line. Molecular endocrinology (Baltimore, Md.). 15 [PubMed]

Shen W, Hamilton SE, Nathanson NM, Surmeier DJ. (2005). Cholinergic suppression of KCNQ channel currents enhances excitability of striatal medium spiny neurons. The Journal of neuroscience : the official journal of the Society for Neuroscience. 25 [PubMed]

Shepard PD, Stump D. (1999). Nifedipine blocks apamin-induced bursting activity in nigral dopamine-containing neurons. Brain research. 817 [PubMed]

Song WJ et al. (1998). Somatodendritic depolarization-activated potassium currents in rat neostriatal cholinergic interneurons are predominantly of the A type and attributable to coexpression of Kv4.2 and Kv4.1 subunits. The Journal of neuroscience : the official journal of the Society for Neuroscience. 18 [PubMed]

Surmeier DJ, Mercer JN, Chan CS. (2005). Autonomous pacemakers in the basal ganglia: who needs excitatory synapses anyway? Current opinion in neurobiology. 15 [PubMed]

Surmeier DJ, Song WJ, Yan Z. (1996). Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. The Journal of neuroscience : the official journal of the Society for Neuroscience. 16 [PubMed]

Swerdlow RH et al. (1996). Origin and functional consequences of the complex I defect in Parkinson's disease. Annals of neurology. 40 [PubMed]

Tkatch T, Baranauskas G, Surmeier DJ. (1998). Basal forebrain neurons adjacent to the globus pallidus co-express GABAergic and cholinergic marker mRNAs. Neuroreport. 9 [PubMed]

Verkhratsky A. (2005). Physiology and pathophysiology of the calcium store in the endoplasmic reticulum of neurons. Physiological reviews. 85 [PubMed]

Wang J, Chen S, Nolan MF, Siegelbaum SA. (2002). Activity-dependent regulation of HCN pacemaker channels by cyclic AMP: signaling through dynamic allosteric coupling. Neuron. 36 [PubMed]

Wilson CJ, Callaway JC. (2000). Coupled oscillator model of the dopaminergic neuron of the substantia nigra. Journal of neurophysiology. 83 [PubMed]

Xu W, Lipscombe D. (2001). Neuronal Ca(V)1.3alpha(1) L-type channels activate at relatively hyperpolarized membrane potentials and are incompletely inhibited by dihydropyridines. The Journal of neuroscience : the official journal of the Society for Neuroscience. 21 [PubMed]

Yamada T, McGeer PL, Baimbridge KG, McGeer EG. (1990). Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K. Brain research. 526 [PubMed]

Yung WH, Häusser MA, Jack JJ. (1991). Electrophysiology of dopaminergic and non-dopaminergic neurones of the guinea-pig substantia nigra pars compacta in vitro. The Journal of physiology. 436 [PubMed]

Zecca L, Zucca FA, Wilms H, Sulzer D. (2003). Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics. Trends in neurosciences. 26 [PubMed]

Zhang L et al. (2005). Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis. Human molecular genetics. 14 [PubMed]

Zolles G et al. (2006). Pacemaking by HCN channels requires interaction with phosphoinositides. Neuron. 52 [PubMed]

References and models that cite this paper

Carnevale NT, Morse TM. (1996). Research reports that have used NEURON Web published citations at the NEURON website.

Dougalis AG, Matthews GAC, Liss B, Ungless MA. (2017). Ionic currents influencing spontaneous firing and pacemaker frequency in dopamine neurons of the ventrolateral periaqueductal gray and dorsal raphe nucleus (vlPAG/DRN): A voltage-clamp and computational modelling study. Journal of computational neuroscience. 42 [PubMed]

Johnson MD, McIntyre CC. (2008). Quantifying the neural elements activated and inhibited by globus pallidus deep brain stimulation. Journal of neurophysiology. 100 [PubMed]

Knowlton C, Kutterer S, Roeper J, Canavier CC. (2018). Calcium dynamics control K-ATP channel-mediated bursting in substantia nigra dopamine neurons: a combined experimental and modeling study. Journal of neurophysiology. 119 [PubMed]

Kuznetsova AY, Huertas MA, Kuznetsov AS, Paladini CA, Canavier CC. (2010). Regulation of firing frequency in a computational model of a midbrain dopaminergic neuron. Journal of computational neuroscience. 28 [PubMed]

Parekh R, Ascoli GA. (2013). Neuronal morphology goes digital: a research hub for cellular and system neuroscience. Neuron. 77 [PubMed]

Rumbell T, Kozloski J. (2019). Dimensions of control for subthreshold oscillations and spontaneous firing in dopamine neurons PLOS Computational Biology. 15

This website requires cookies and limited processing of your personal data in order to function. By continuing to browse or otherwise use this site, you are agreeing to this use. See our Privacy policy and how to cite and terms of use.